As non-invasive prenatal testing (NIPT) continues to develop and its uptake quickly rises worldwide, appropriate validation and quality controls are required to ensure the highest testing quality and safety for patients. This could also ensure compliance with International Standardization Organization (ISO) standards, local regulations, and guidelines. However, validating such assays can seem trivial as the conditions screened for are rare, and obtaining the samples can be challenging.
This white paper from LGC SeraCare presents data demonstrating that Seraseq reference samples can be run successfully on an NIPT assay from extraction to sequencing, presenting an alternative solution to hard-to-source patient samples, and offering full-process patient-like materials that are compatible with NIPT platforms.
Offered Free by: LGC SeraCare Life Sciences
See All Resources from: LGC SeraCare Life Sciences